Glucocorticoids modify effects of TGF-β1 on multidrug resistance in the fetal blood-brain barrier

References

• Agarwal S, Hartz AMS, Elmquist WF, Bauer B. 2011. Breast cancer resistance protein and P-glycoprotein in brain cancer: Two gatekeepers team up. Curr Pharm Des 17:2793–2802
   PubMed Web of Science ®Google Scholar
• Anacker C, Cattaneo A, Luoni A, Musaelyan K, Zunszain PA, Milanesi E, Rybka J, et al. 2013. Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. Neuropsychopharmacology 38:872–883
   PubMed Web of Science ®Google Scholar
• Baello S, Iqbal M, Bloise E, Javam M, Gibb W, Matthews SG. 2014. TGF-β1 regulation of multidrug resistance P-glycoprotein in the developing male blood-brain barrier. Endocrinology 155:475–484
   PubMed Web of Science ®Google Scholar
• Bain LJ, McLachlan JB, LeBlanc GA. 1997. Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein. Environ Health Perspect 105:812–818
   PubMed Web of Science ®Google Scholar
• Ballard PL, Ballard RA. 1995. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 173:254–262
   PubMed Web of Science ®Google Scholar
• Bendayan R, Lee G, Bendayan M. 2002. Functional expression and localization of P-glycoprotein at the blood brain barrier. Microsc Res Tech 57:365–380
   PubMed Web of Science ®Google Scholar
• Bertossi M, Virgintino D, Errede M, Roncali L. 1999. Immunohistochemical and ultrastructural characterization of cortical plate microvasculature in the human fetus telencephalon. Microvasc Res 58:49–61
   PubMed Web of Science ®Google Scholar
• Bleier BS, Nocera AL, Iqbal H, Hoang JD, Feldman RE, Han X. 2013. P-glycoprotein functions as an immunomodulator in healthy human primary nasal epithelial cells. Int Forum Aller Rhinol 3:433–438
   PubMed Web of Science ®Google Scholar
• Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, et al. 2012. Dysfunction of TGF-β1 signaling in Alzheimer’s disease: Perspectives for neuroprotection. Cell Tiss Res 347:291–301
   PubMed Web of Science ®Google Scholar
• Ciarmela P, Bloise E, Gray PC, Carrarelli P, Islam MS, De Pascalis F, Severi FM, et al. 2011. Activin-A and myostatin response and steroid regulation in human myometrium: Disruption of their signalling in uterine fibroid. J Clin Endocrinol Metab 96:755–765
   PubMed Web of Science ®Google Scholar
• Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, Jiang H, et al. 2005. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 115:3285–3290
   PubMed Web of Science ®Google Scholar
• Deo AK, Borson S, Link JM, Domino K, Eary JF, Ke B, Richards TL, et al. 2014. Activity of P-glycoprotein, a beta-amyloid transporter at the blood-brain barrier, is compromised in patients with mild Alzheimer disease. J Nucl Med 55:1106–1111
   PubMed Web of Science ®Google Scholar
• Dobbing J, Sands J. 1970. Growth and development of the brain and spinal cord of the guinea pig. Brain Res 17:115–123
   PubMed Web of Science ®Google Scholar
• Dolghih E, Jacobson MP. 2013. Predicting efflux ratios and blood-brain barrier penetration from chemical structure: Combining passive permeability with active efflux by P-glycoprotein. ACS Chem Neurosci 4:361–367
   PubMed Web of Science ®Google Scholar
• Duncan AR, Sadowska GB, Stonestreet BS. 2009. Ontogeny and the effects of exogenous and endogenous glucocorticoids on tight junction protein expression in ovine cerebral cortices. Brain Res 1303:15–25
   PubMed Web of Science ®Google Scholar
• Finnson KW, Parker WL, Chi Y, Hoemann CD, Goldring MB, Antoniou J, Philip A. 2010. Endoglin differentially regulates TGF-beta-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and cellular differentiation state in human chondrocytes. Osteoarthr Cartil 18:1518–1527
   PubMed Web of Science ®Google Scholar
• Frahm KA, Tobet SA. 2015. Development of the blood-brain barrier within the paraventricular nucleus of the hypothalamus: Influence of fetal glucocorticoid excess. Brain Struc Func 220:2225–2234
   PubMed Web of Science ®Google Scholar
• Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. 2002. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21:1743–1753
   PubMed Web of Science ®Google Scholar
• Hai CM, Sadowska G, Francois L, Stonestreet BS. 2002. Maternal dexamethasone treatment alters myosin isoform expression and contractile dynamics in fetal arteries. Am J Physiol Heart Circ Physiol 283:H1743–H1749
   Google Scholar
• Iqbal M, Gibb W, Matthews SG. 2011. Corticosteroid regulation of P-glycoprotein in the developing blood-brain barrier. Endocrinology 152:1067–1079
   PubMed Web of Science ®Google Scholar
• Kantharidis P, El-Osta A, deSilva M, Wall DM, Hu XF, Slater A, Nadalin G, et al. 1997. Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance. Clin Cancer Res 3:2025–2032
   PubMed Web of Science ®Google Scholar
• Kawakami T, Ihn H, Xu W, Smith E, LeRoy C, Trojanowska M. 1998. Increased expression of TGF-beta receptors by scleroderma fibroblasts: Evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype. J Invest Dermatol 110:47–51
   PubMed Web of Science ®Google Scholar
• Keightley MC, Curtis AJ, Chu S, Fuller PJ. 1998. Structural determinants of cortisol resistance in the guinea pig glucocorticoid receptor. Endocrinology 139:2479–2485
   PubMed Web of Science ®Google Scholar
• Kleeff J, Korc M. 1998. Up-regulation of transforming growth factor (TGF)-beta receptors by TGF-beta1 in COLO-357 cells. J Biol Chem 273:7495–7500
   PubMed Web of Science ®Google Scholar
• Kniesel U, Risau W, Wolburg H. 1996. Development of blood-brain barrier tight junctions in the rat cortex. Brain Res Dev Brain Res 96:229–240
   PubMedGoogle Scholar
• Kooij G, Mizee MR, van Horssen J, Reijerkerk A, Witte ME, Drexhage JA, van der Pol SM, et al. 2011. Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: Relevance to multiple sclerosis pathogenesis. Brain 134:555–570
   PubMed Web of Science ®Google Scholar
• Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH. 2005. Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo. Ann Neurol 57:176–179
   PubMed Web of Science ®Google Scholar
• Lam J, Baello S, Iqbal M, Kelly LE, Shannon PT, Chitayat D, Matthews SG, Koren G. 2015. The ontogeny of P-glycoprotein in the developing human blood brain barrier: Implication for opioid toxicity in neonates. Pediatr Res 78:417–421
   PubMed Web of Science ®Google Scholar
• Lankas GR, Wise LD, Cartwright ME, Pippert T, Umbenhauer DR. 1998. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod Toxicol 12:457–463
   PubMed Web of Science ®Google Scholar
• Leask A, Abraham DJ. 2004. TGF-beta signaling and the fibrotic response. FASEB J 18:816–827
   PubMed Web of Science ®Google Scholar
• Massagué J, Attisano L, Wrana JL. 1994. The TGF-β family and its composite receptors. Trends Cell Biol 4:172–178
   PubMedGoogle Scholar
• Massague J, Blain SW, Lo RS. 2000. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103:295–309
   PubMed Web of Science ®Google Scholar
• Massague J, Seoane J, Wotton D. 2005. Smad transcription factors. Genes Dev 19:2783–2810
   PubMed Web of Science ®Google Scholar
• Massague J. 1998. TGF-beta signal transduction. Annu Rev Biochem 67:753–791
   PubMed Web of Science ®Google Scholar
• Moisiadis VG, Matthews SG. 2014. Glucocorticoids and fetal programming part 2: Mechanisms. Nat Rev Endocrinol 10:403–411
   PubMed Web of Science ®Google Scholar
• Molnar J, Nijland MJ, Howe DC, Nathanielsz PW. 2002. Evidence for microvascular dysfunction after prenatal dexamethasone at 0.7, 0.75, and 0.8 gestation in sheep. Am J Physiol Regul Integ Comp Physiol 283:R561–R567
   Google Scholar
• Nico B, Quondamatteo F, Herken R, Marzullo A, Corsi P, Bertossi M, Russo G, et al. 1999. Developmental expression of ZO-1 antigen in the mouse blood-brain barrier. Brain Res Dev Brain Res 114:161–169
   PubMedGoogle Scholar
• Nicolas FJ, Hill CS. 2003. Attenuation of the TGF-beta-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-beta-induced growth arrest. Oncogene 22:3698–3711
   PubMed Web of Science ®Google Scholar
• Pawlik A, Baskiewicz-Masiuk M, Machalinski B, Safranow K, Gawronska-Szklarz B. 2005. Involvement of P-glycoprotein in the release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. J Pharm Pharmacol 57:1421–1425
   PubMed Web of Science ®Google Scholar
• Petropoulos S, Gibb W, Matthews SG. 2010. Developmental expression of multidrug resistance phosphoglycoprotein (P-gp) in the mouse fetal brain and glucocorticoid regulation. Brain Res 1357:9–18
   PubMed Web of Science ®Google Scholar
• Sadowska GB, Malaeb SN, Stonestreet BS. 2010. Maternal glucocorticoid exposure alters tight junction protein expression in the brain of fetal sheep. Am J Physiol Heart Circul Physiol 298:H179–H188
   Google Scholar
• Saunders NR, Knott GW, Dziegielewska KM. 2000. Barriers in the immature brain. Cell Mol Neurobiol 20:29–40
   PubMed Web of Science ®Google Scholar
• Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, van der Valk MA, et al. 1997. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 94:4028–4033
   PubMed Web of Science ®Google Scholar
• Sozen I, Arici A. 2002. Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil Steril 78:1–12
   PubMed Web of Science ®Google Scholar
• Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA. 2002. Consequences of altered TGF-beta expression and responsiveness in breast cancer: Evidence for autocrine and paracrine effects. Oncogene 21:108–118
   PubMed Web of Science ®Google Scholar
• van Assema DM, Lubberink M, Bauer M, van der Flier WM, Schuit RC, Windhorst AD, Comans EF, et al. 2012. Blood-brain barrier P-glycoprotein function in Alzheimer’s disease. Brain 135:181–189
   PubMed Web of Science ®Google Scholar
• Vinukonda G, Dummula K, Malik S, Hu F, Thompson CI, Csiszar A, Ungvari Z, Ballabh P. 2010. Effect of prenatal glucocorticoids on cerebral vasculature of the developing brain. Stroke 41:1766–1773
   PubMed Web of Science ®Google Scholar
• Virgintino D, Errede M, Robertson D, Capobianco C, Girolamo F, Vimercati A, Bertossi M, Roncali L. 2004. Immunolocalization of tight junction proteins in the adult and developing human brain. Histochem Cell Biol 122:51–59
   PubMed Web of Science ®Google Scholar
• Vogelgesang S, Cascorbi I, Schroeder E, Pahnke J, Kroemer HK, Siegmund W, Kunert-Keil C, et al. 2002. Deposition of Alzheimer’s beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 12:535–541
   PubMedGoogle Scholar
• Wu X, Ma J, Han JD, Wang N, Chen YG. 2006. Distinct regulation of gene expression in human endothelial cells by TGF-beta and its receptors. Microvasc Res 71:12–19
   PubMed Web of Science ®Google Scholar
• Yan X, Liu Z, Chen Y. 2009. Regulation of TGF-beta signaling by Smad7. Acta Biochim Biophys Sin 41:263–272
   Google Scholar
• Yates CR, Chang C, Kearbey JD, Yasuda K, Schuetz EG, Miller DD, Dalton JT, Swaan PW. 2003. Structural determinants of P-glycoprotein-mediated transport of glucocorticoids. Pharm Res 20:1794–1803
   PubMed Web of Science ®Google Scholar
• Zhou SF. 2008. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38:802–832
   PubMed Web of Science ®Google Scholar